Please assess the completion status of the following clinical trial:

Trial Title: Positron Emission Tomography-Computed Tomography (PET-CT) High-grade Glioma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed gliomas III - IV (glioblastoma, anaplastic astrocytoma, gliosarcoma) at primary diagnosis;~* WhO PFS \<= 2~* Tumours which do enhance on pre-operative imaging.~* Post-operative enough visible residual tumour on PET or status after biopsy only~* Age \>18 years~* Availability of deep fresh frozen tissue for molecular biologic evaluation - if possible~* Patient able to tolerate full course of conventional RT and follow serial scanning~* No previous radiotherapy to the head and neck and brain area.~* Prior neurosurgery within 6 weeks of treatment~* No previous chemotherapy before treatment of the glioma. Standard radiochemotherapy with temozolomide is not excluded~* No prior or concurrent medical condition which would make treatment difficult to complete. Medication with steroids is allowed.~* No incapacitated patients.~Exclusion Criteria:~* Not histologically confirmed gliomas III - IV (glioblastoma, anaplastic astrocytoma, gliosarcoma) at primary diagnosis;~* WhO PFS \> 2~* No tumours which do enhance on pre-operative imaging.~* Post-operative not enough visible residual tumor on PET or status after biopsy only~* Age \<18 years~* No availability of deep fresh frozen tissue for molecular biologic evaluation~* Patient not able to tolerate full course of conventional RT and follow serial scanning~* Previous radiotherapy to the head and neck and brain area.~* Prior neurosurgery not within 6 weeks of treatment~* Previous chemotherapy before treatment of the glioma.~* Prior or concurrent medical condition which would make treatment difficult to complete.~* Incapacitated patients.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Observational (Type: None): Patients with a primary glioblastoma

Based on this trial design, predict the completion outcome and termination type (if applicable).